References
- Spranger J, Lo L. Spondyloepiphyseal dysplasia congenita. Radiology 1970; 94: 313–322
- Augenstein K, Ward M, Nelson V. Spondyloepiphyseal dysplasia congenita with ventilator dependence: Two case reports. Arch Phys Med Rehab 1996; 77: 1201–1204
- Travadi J N, Patole S K. Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review. Pediatr Pulmonol 2003; 36: 529–535
- Lobato E B, Beaver T, Muehlschlegel J, Kirby D S, Klodell C, Sidi A. Br J Anaesth 2006; 96: 317–322
- Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nadgyman N, Hubler M, Butrous G, Petros A, Lange P, Redington A. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003; 108: 167–173
- Erickson S, Reyes J, Bohn D, Adatia I. Sildenafil (viagra) in childhood and neonatal pulmonary hypertension. J Am Coll Cardiol 2002; 39: 402
- Juliana A E, Abbad F C. Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: Successful treatment with sildenafil. Eur J Pediatr 2005; 164: 626–629
- Marsh C S, Marden B, Newsom R. Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol 2004; 88: 306–307
- Chaudhari M, Vogel M, Wright C, Smith J, Haworth S G. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy. Arch Dis Child Fetal Neonatal Ed 2005; 90: F527–F528